Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers, 1 FDA Orange Book

1 FDF Dossiers
1 FDA Orange Book

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Mebutamat, Mebutina, 64-55-1, Butatensin, Carbuten, Ipotensivo

Molecular Formula

C₁₀H₂₀N₂O₄

Molecular Weight

232.28 g/mol

InChI Key

LEROTMJVBFSIMP-UHFFFAOYSA-N

FDA UNII

5H8F175RER

Mebutamate is a sedative and anxiolytic drug with anti-hypertensive (blood pressure lowering) effects comparable to those of other barbiturates but is only around 1/3rd the potency of secobarbital as a sedative. Side effects include dizziness and headaches.

1 2D Structure

Mebutamate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

[2-(carbamoyloxymethyl)-2,3-dimethylpentyl] carbamate

2.1.2 InChI

InChI=1S/C10H20N2O4/c1-4-7(2)10(3,5-15-8(11)13)6-16-9(12)14/h7H,4-6H2,1-3H3,(H2,11,13)(H2,12,14)

2.1.3 InChI Key

LEROTMJVBFSIMP-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CCC(C)C(C)(COC(=O)N)COC(=O)N

2.2 Other Identifiers

2.2.1 UNII

5H8F175RER

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Mebutamat

2. Mebutina

3. 64-55-1

4. Butatensin

5. Carbuten

6. Ipotensivo

7. Mioartrina

8. Preminex

9. Sigmafon

10. Axiten

11. Dormate

12. Encapla

13. Vallene

14. Capla

15. Dicamoylmethtane

16. Prean

17. No-press

18. Dicamoylmethane

19. 2,2-dicarbamyloxymethyl-3-methylpentane

20. 2-methyl-2-(1-methylpropyl)-1,3-propanediol Dicarbamate

21. 2-sec-butyl-2-methyl-1,3-propanediol Dicarbamate

22. 2-sec-butyl-2-methyltrimethylene Dicarbamate

23. W-583

24. 2-methyl-2-sec-butyl-1,3-propanediol Dicarbamate

25. W 583

26. Nsc 163921

27. 1,3-propanediol, 2-methyl-2-(1-methylpropyl)-, Dicarbamate

28. [2-(carbamoyloxymethyl)-2,3-dimethylpentyl] Carbamate

29. Carbamic Acid, 2-sec-butyl-2-methyltrimethylene Ester

30. Nsc-163921

31. 5h8f175rer

32. 2-[(carbamoyloxy)methyl]-2,3-dimethylpentyl Carbamate

33. 1,3-propanediol, 2-sec-butyl-2-methyl-, Dicarbamate

34. 2-sec-butyl-2-methylpropane-1,3-diyl Dicarbamate

35. Mebutamato

36. Mebutamatum

37. Mebutamatum [inn-latin]

38. Mebutamato [inn-spanish]

39. Mebutamate [usan:inn:ban:jan]

40. Einecs 200-587-5

41. Brn 1788226

42. Unii-5h8f175rer

43. Dea No. 2800

44. Dormate (tn)

45. Capla (tn)

46. Caplaril (salt/mix)

47. Mebutamate [mi]

48. Mebutamate [inn]

49. Mebutamate [jan]

50. Mebutamate (jan/usan)

51. Mebutamate [usan]

52. Dsstox_cid_3239

53. Mebutamate [mart.]

54. Dsstox_rid_97548

55. Mebutamate [who-dd]

56. (+/-)-mebutamate

57. Dsstox_gsid_23239

58. Schembl122289

59. Chembl1200922

60. Dtxsid1023239

61. Mebutamate [orange Book]

62. Chebi:31804

63. Lerotmjvbfsimp-uhfffaoysa-

64. Mebutamate, (+/-)-

65. Wln: Zvo1x1&1ovzy2&1

66. Tox21_113666

67. Mfcd00025464

68. Nsc163921

69. Akos027379922

70. Db06797

71. Cas-64-55-1

72. 1, 2-sec-butyl-2-methyl-, Dicarbamate

73. Ncgc00249890-01

74. Db-054688

75. Ft-0631284

76. M1018

77. D01807

78. 1, 2-methyl-2-(1-methylpropyl)-, Dicarbamate

79. Sr-01000944487

80. Q6804368

81. Sr-01000944487-1

82. Z1550648766

83. 1,3-propanediol, 2-methyl-2-(1-methylpropyl)-, 1,3-dicarbamate

2.4 Create Date

2005-03-26

3 Chemical and Physical Properties

Molecular Formula	C₁₀H₂₀N₂O₄
Molecular Weight	232.28 g/mol
XLogP3	1.4
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	8
Exact Mass	232.14230712 g/mol
Monoisotopic Mass	232.14230712 g/mol
Topological Polar Surface Area	105 Å²
Heavy Atom Count	16
Formal Charge	0
Complexity	237
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 ATC Code

N - Nervous system

N05 - Psycholeptics

N05B - Anxiolytics

N05BC - Carbamates

N05BC04 - Mebutamate

FDF Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Find Mebutamate manufacturers, exporters & distributors on PharmaCompass

Mebutamate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers

1 FDA Orange Book

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?